Trv Gp Iv, LLC 13F Filing — Q2 2023 Positions | AlphaSMO

Trv Gp Iv, LLC — Q2 2023 13F Holdings

Name: Trv Gp Iv, LLC — 13F Holdings, Q2 2023
Creator: AlphaSMO
License: https://www.sec.gov/forms

CIK: 0001688325

Total reported value

$266.9M

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change
1	TNGX	Tango Therapeutics INC	Stock-Other	58.09%	+22.61%	—
2	PLRX	Pliant Therapeutics INC	Stock-Other	34.92%	—	—
3	FULC	Fulcrum Therapeutics INC	Stock-Other	6.99%	—	—